Schedule 13D ownership disclosure

REGENERX BIOPHARMACEUTICALS CO

Security class unavailable · CUSIP: 75886X108

Event date: 2023-07-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
34.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-23-055191
Form type
SC 13D/A
Filer
Essetifin SPA
CIK
CIK 1092601
Filed
Jul 06, 2023
Reporting period
Jul 03, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub